Disappearance curves for tumor markers after resection of intrathoracic malignancies

被引:47
作者
Yoshimasu, T [1 ]
Maebeya, S [1 ]
Suzuma, T [1 ]
Bessho, T [1 ]
Tanino, H [1 ]
Arimoto, J [1 ]
Sakurai, T [1 ]
Naito, Y [1 ]
机构
[1] Wakayama Med Coll, Dept Thorac & Cardiovasc Surg, Wakayama 6408156, Japan
关键词
elimination kinetics; biological half-life; lung cancer; surgery;
D O I
10.1177/172460089901400207
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Determination of the standard elimination kinetics of tumor markers will be helpful in rite diagnosis of malignancies. We analyzed the disappearance curves for serum tumor marker levels after resection of intrathoracic malignancies. Serum levels of CEA, SLX, AFP, CA 19-9, SCC, TPA and CYFRA were measured several rimes after surgery in a total of 40 patients. To obtain precise biological half-lives, we applied non-linear least square analysis, taking into consideration the possibility of residual tumor cells. Disappearance curves were monophasic for CEA, SCC, TPA, CYFRA and SLX and biphasic for CA 19-9 and AFP. Temporary elevation of serum levels after surgery Mas observed for SCC, TPA and CYFRA. The average half-lives of CEA, SLX, SCC, TPA and CYFRA were 1.5 days, 2.7 days, 2.2 hours, 2.5 hours and 1.5 hours, respectively. The average half-life of CA 19-9 was 0.5 days in the first compartment and 4.3 days in the second compartment, while that of AFP was 1.0 days and 6.3 days, respectively. These values will be helpful in the interpretation of serum tumor marker levels after surgery.
引用
收藏
页码:99 / 105
页数:7
相关论文
共 21 条
[1]   MECHANISM OF CLEARANCE OF CIRCULATING CA19-9 IN RATS [J].
ADACHI, M ;
SEKINE, T ;
UMEMOTO, A ;
TSUKIKAWA, S ;
IMAI, K ;
YACHI, A .
TUMOR BIOLOGY, 1990, 11 (1-2) :51-58
[2]  
Akaike H., 1973, 2 INT S INFORM THEOR, P267, DOI [DOI 10.1007/978-1-4612-1694-0_15, 10.1007/978-1-4612-1694-0_15]
[3]  
LANGE PH, 1982, J UROLOGY, V128, P708, DOI 10.1016/S0022-5347(17)53149-3
[4]  
PECCHIO F, 1992, International Journal of Biological Markers, V7, P119
[5]   Acquired renal cystic disease and tumor markers in chronic hemodialysis patients [J].
Polenakovic, M ;
Sikole, A ;
Dzikova, S ;
Polenakovic, B ;
Gelev, S .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1997, 20 (02) :96-100
[6]  
RODRIGUS P, 1992, Strahlentherapie und Onkologie, V168, P397
[7]  
Sarwar M, 1994, Ann Nucl Med, V8, P301
[8]  
SEE WA, 1993, CANCER, V71, P2048, DOI 10.1002/1097-0142(19930315)71:6<2048::AID-CNCR2820710620>3.0.CO
[9]  
2-R
[10]  
Semjonow A., 1994, International Journal of Biological Markers, V9, P15